Propogation and Characterization of 2 Mouse Embryonic Stem Cell Lines
2 种小鼠胚胎干细胞系的增殖和表征
基本信息
- 批准号:7497843
- 负责人:
- 金额:$ 2.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-16 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:Biological AssayCell LineCellsCommunitiesConditionDataES Cell LineEngineeringFutureGene MutationGeneticGerm LinesGoalsGrantGreen Fluorescent ProteinsHandHybridsIn VitroKnock-outKnockout MiceLaboratoriesLaboratory miceMonitorMusNational Center for Research ResourcesNumbersPhasePrincipal InvestigatorProtocols documentationQuality ControlRateResearchResearch PersonnelResourcesSafetyScreening procedureSmall Business Funding MechanismsSmall Business Innovation Research GrantStandardizationStem cellsSterilityStudy modelsTerminal Repeat SequencesTestingTransgenesTransgenic MiceUndifferentiatedWorkcell bankembryonic stem cellexperiencegene functionhomologous recombinationhuman diseasein vivomouse genomemouse modelpathogenpluripotencyprogramsresearch studyscale uptransmission process
项目摘要
The laboratory mouse is a popular model for the study of human disease. In the recent
past, the mouse has also become widely used for the analysis of mammalian gene
function. The genome of the mouse is relatively accessible and, thus, many transgenic
mice have been engineered. Homologous recombination in mouse embryonic stem cells
has been a convenient vehicle for the creation of these transgenic mice. One major,
rate-limiting factor for the determination of gene function has been the lack of access to
validated, germline competent mouse ES cell lines from various genetic backgrounds.
The newly launched NIH-sponsored program entitled Knockout Mouse Project (KOMP)
is striving to generate a complete or nearly complete set of knockout mutations of the
genes in the mouse genome on the C57Bl/6 genetic background. Our proposal is
complementary to the KOMP project in that one of the lines we are proposing to use is a
C57Bl/6 (line LB10) and the other line is an F1 hybrid C57Bl/6 x 129 (line LC3). Both
lines are homozygous for a ubiquitously expressed GFP transgene. The ability to
compare results across laboratories requires that studies be performed on the same
starting material. Ample evidence for genotypic and phenotypic changes, partially
induced through improper handling during culture, exists regarding the propagation of
ES cell lines. Here, we propose to standardize, propagate, and thoroughly characterize
two mouse ES cell lines, LC3 and LB10. The ultimate goal of this application is to make
ES cell lines from useful mouse models readily accessible to the scientific community.
Specifically, our aims are:
Aim I. Establish Master and Working Cell Banks for each mouse ES cell line.
Aim II. Fully characterize the two mouse ES cell lines and prepare them for
distribution.
Work under Aim I will include standardization of culture conditions for the two lines and
expansion of the cells under those conditions, while under Aim II we will monitor for
changes in pluripotency during in vitro propagation. Our ultimate test for pluripotency will
be assaying the ES cell lines for their ability to populate the germ lines of mice. Future
work will include scale-up and distribution of these lines to the scientific community along
with the inclusion of other important mouse ES lines in this program.
实验室小鼠是研究人类疾病的流行模型。近
过去,小鼠也被广泛用于分析哺乳动物的基因
功能小鼠的基因组相对容易获得,因此,许多转基因小鼠都可以获得。
老鼠已经被改造过了。小鼠胚胎干细胞的同源重组
已经成为创造这些转基因小鼠的便利载体。一个少校,
决定基因功能的一个限速因素是缺乏获得
来自各种遗传背景的经验证的生殖系感受态小鼠ES细胞系。
新推出的NIH赞助的项目, 基因敲除小鼠项目(KOMP)
正在努力产生一个完整的或几乎完整的基因敲除突变的集合,
小鼠基因组中的C57 B1/6基因背景。我们的建议是
补充KOMP项目,我们建议使用的线路之一是
C57 B1/6(品系LB 10),另一个品系是F1杂种C57 B1/6 × 129(品系LC 3)。两
品系对于普遍表达的GFP转基因是纯合的。的能力
比较实验室之间的结果要求在相同的实验室中进行研究。
起始材料充分的证据表明基因型和表型的变化,部分
在培养过程中,由于处理不当而引起的,
ES细胞系。在这里,我们建议标准化,宣传和彻底表征
两种小鼠ES细胞系,LC 3和LB 10。该应用程序的最终目标是使
ES细胞系来自科学界容易获得的有用的小鼠模型。
具体而言,我们的目标是:
艾姆岛建立每个小鼠ES细胞系的主细胞库和工作细胞库。
Aim II.充分表征两种小鼠ES细胞系,并将其制备用于
分布
目标I下的工作将包括两条生产线培养条件的标准化,
在这些条件下,细胞的扩增,而在目标II下,我们将监测
在体外繁殖过程中多能性的变化。我们对多能性的终极测试
检测胚胎干细胞系在小鼠生殖细胞系中的繁殖能力。未来
工作将包括扩大这些生产线的规模,并将其分发给沿着的科学界
在这个程序中包括其他重要的小鼠ES系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JONATHAN M. AUERBACH其他文献
JONATHAN M. AUERBACH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JONATHAN M. AUERBACH', 18)}}的其他基金
mRNA-Directed Differentiation of hPSC to A10 Dopaminergic Neurons
hPSC mRNA 定向分化为 A10 多巴胺能神经元
- 批准号:
9199485 - 财政年份:2016
- 资助金额:
$ 2.89万 - 项目类别:
Streamlined Banking of Human Pluripotent Stem Cells Through Molecular Authenticat
通过分子验证简化人类多能干细胞的存储
- 批准号:
7802771 - 财政年份:2010
- 资助金额:
$ 2.89万 - 项目类别:
Characterization of a cell line for use as a reference standard for human embryon
用作人类胚胎参考标准的细胞系的表征
- 批准号:
7404988 - 财政年份:2008
- 资助金额:
$ 2.89万 - 项目类别:
Characterization of a cell line for use as a reference standard for human embryon
用作人类胚胎参考标准的细胞系的表征
- 批准号:
7676596 - 财政年份:2008
- 资助金额:
$ 2.89万 - 项目类别:
Propogation and Characterization of 2 Mouse Embryonic Stem Cell Lines
2 种小鼠胚胎干细胞系的增殖和表征
- 批准号:
7326500 - 财政年份:2007
- 资助金额:
$ 2.89万 - 项目类别:
Propogation and Characterization of 2 Mouse Embryonic Stem Cell Lines
2 种小鼠胚胎干细胞系的增殖和表征
- 批准号:
7622910 - 财政年份:2007
- 资助金额:
$ 2.89万 - 项目类别:
Propogation and Characterization of 2 Mouse Embryonic Stem Cell Lines
2 种小鼠胚胎干细胞系的增殖和表征
- 批准号:
7865861 - 财政年份:2007
- 资助金额:
$ 2.89万 - 项目类别:
相似海外基金
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 2.89万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 2.89万 - 项目类别:
Basic studies of low-dose cisplatin-based concurrent chemoradiotherapy on human cervix carcinoma cells (HeLa cell line)
小剂量顺铂同步放化疗对人宫颈癌细胞(HeLa细胞系)的基础研究
- 批准号:
17K16425 - 财政年份:2017
- 资助金额:
$ 2.89万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Differential expression of cell adhesion molecule of CD133-positive / negative cells derived from oral cancer cell line and diagnostic treatment targeting it
口腔癌细胞系CD133阳性/阴性细胞细胞粘附分子的差异表达及针对其的诊断治疗
- 批准号:
17K17251 - 财政年份:2017
- 资助金额:
$ 2.89万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Deveopment of methods to establish cell-line of parathyroid cells
甲状旁腺细胞系建立方法的开发
- 批准号:
16K09628 - 财政年份:2016
- 资助金额:
$ 2.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SBIR Phase II: A novel multicolor cell line engineering platform that enables high-throughput microscopy-based screening of living cells for drug discovery
SBIR II 期:一种新型多色细胞系工程平台,可实现基于高通量显微镜的活细胞筛选以用于药物发现
- 批准号:
1632576 - 财政年份:2016
- 资助金额:
$ 2.89万 - 项目类别:
Standard Grant
The analysis of heme synthesis mechanism and the establishment of disease model cells for X-linked sideroblastic anemia using an immortalized human erythroid cell line.
利用永生化人红细胞系分析血红素合成机制并建立X连锁铁粒幼细胞贫血疾病模型细胞。
- 批准号:
15K19539 - 财政年份:2015
- 资助金额:
$ 2.89万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
SBIR Phase I: A novel multicolor cell line engineering platform that enables high-throughput microscopy-based screening of living cells for drug discovery
SBIR 第一阶段:一种新型多色细胞系工程平台,可实现基于高通量显微镜的活细胞筛选以用于药物发现
- 批准号:
1448764 - 财政年份:2015
- 资助金额:
$ 2.89万 - 项目类别:
Standard Grant
Elucidation of characteristic alterations of spermatogonial stem cells in testicular cancer and application to genome-based drug discovery using novel cell line
阐明睾丸癌中精原干细胞的特征改变以及使用新型细胞系在基于基因组的药物发现中的应用
- 批准号:
26462421 - 财政年份:2014
- 资助金额:
$ 2.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of lacrimal gland epithelial cell line for the evaluation of lacrimal gland cells
泪腺上皮细胞系的建立用于泪腺细胞的评价
- 批准号:
24592650 - 财政年份:2012
- 资助金额:
$ 2.89万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




